New non-invasive tool for melanoma detection

DID YOU KNOW?

We are also a Center for Skin Cancer. The Appearance Center is under the same roof and the same leadership as the Skin Cancer and Reconstructive Surgery Center. Our Appearance Center physicians also treat skin cancer patients, performing complex cancer reconstructions, and addressing post-cancer cosmetic issues.

We want ALL of our patients to know about an exciting new technology to help with the diagnosis of melanoma. We are excited to provide Nevisense, a novel tool for detection of melanoma. This FDA-approved, non-invasive, and highly accurate device allows for early detection of potential melanomas without the need for skin biopsies.

Nevisense: A Groundbreaking Approach to Early Detection

Nevisense is a cutting-edge technology designed to address the limitations of traditional melanoma detection methods. Developed by SciBase, a Swedish medical technology company, Nevisense employs Electrical Impedance Spectroscopy (EIS) to non-invasively analyze the electrical properties of skin lesions. This innovative approach allows for a more accurate and objective assessment of melanoma risk.

How Nevisense Works

Nevisense works by measuring the electrical impedance of the skin at different frequencies. The device sends a painless, low-frequency electrical signal into the skin, and the resulting impedance data is analyzed by an AI algorithm. The impedance patterns produces by melanomas are different from those of benign moles. 

Key Advantages of Nevisense

1. Non-Invasive and Painless: Nevisense is a non-invasive procedure that does not require the removal of tissue for analysis. This makes it a more comfortable experience for patients compared to traditional biopsy methods.
2. Objective and Quantifiable: The electrical impedance measurements provide an objective and quantifiable assessment of skin lesions, reducing the subjectivity associated with visual inspections.
3. Early Detection: Nevisense has demonstrated a high sensitivity for detecting melanoma at its earliest stages, allowing for prompt intervention and improved treatment outcomes.
4. Complementary to Visual Inspection: Nevisense is designed to complement traditional visual inspection methods, offering a comprehensive approach to melanoma detection.

Schedule a skin check at the SCARS Center to see if you are a candidate for this groundbreaking diagnostic tool.